Company / Return on Equity (ROE)
MIMEDX GROUP, INC. Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
18.9%
FY2025
5-year range
18.9% / 40.8%
FY2021-FY2025
Trend
-13.8%
vs FY2024
Sector context
#25 of 147
Health Care
What the data says
MIMEDX GROUP, INC.'s return on equity (roe) of 18.9% is higher than 83% of companies in the Health Care sector (FY2025). Return on Equity (ROE) has fluctuated over the past 7 years, ranging from -74.4% in FY2019 to 87.7% in FY2017.
Based on SEC 10-K filings.
18.9% in FY2025. Top quartile in the Health Care sector.
Declined from 40.8% to 18.9% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
+683.7% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 13.8% year-over-year.
- Currently 22.2pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2017.
- Lowest return on equity (roe) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.50 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 18.9% | -13.8% |
| FY2024 | 22.0% | -46.2% |
| FY2023 | 40.8% | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | -74.4% | -23.2% |
| FY2018 | -60.4% | -168.8% |
| FY2017 | 87.7% | +10728.4% |
| FY2016 | 0.8% | -99.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026